VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY. (June 2017) - Swinnen, L.J.; Flowers, C.R.; Wang, D.; Reid, E.; Fowler, N.; Cordero, J.; Dunbar, M.; Enschede, S.; Nolan, C.; Petrich, A.M.; Ross, J.; Salem, A.H.; et al.